What Next | Daily News and Analysis - On A Wild Goose Chase for Masks

The global scarcity of masks has shown us the federal government’s desperate side. Procurement rules have been loosened. Prices have soared. And a shadowy market has emerged where deals fall through all the time -- leaving people without the gear they need to protect themselves and save lives. 

Guest: J. David McSwane, reporter for ProPublica. 

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.


Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - Can We Even Trust the Testing Data?

We closed down the country because we didn’t have enough COVID-19 tests. Now that testing capacity is improving, there’s another problem: figuring out what all this new data means, and who’s reporting accurate figures. 

Guest: Robinson Meyer, staff writer at the Atlantic, and part of the team working on the COVID Tracking Project

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - How Much Trouble Is Senator Richard Burr In?

A lot happened in February for Senator Ricard Burr (R-NC). He told his constituents that the country was “ready to face the coronavirus.” He told a members-only club that they should expect school closures, canceled travel, and overwhelmed hospitals. And he sold a bunch of his stock. Now, Burr is under a federal investigation for possible insider trading. 

Guest: Tim Mak, Washington investigative correspondent for NPR. 

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - TBD | Decoding the Flood of COVID Data

Every week, it feels like some new piece of coronavirus information dominates the headlines. Mysterious symptoms, changing government directives. This constant trickle of updates can quickly turn into a flood.


How should normal people interpret this deluge of data?


Guest: Emily Oster, professor of economics at Brown University and co-founder of COVID-Explained


Host

Lizzie O’Leary

 

 

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - Inside a COVID-19 Vaccine Trial

All around the world, scientific research has been put on hold to concentrate resources on one thing: a vaccine for COVID-19. The usual red tape that slows down these experiments has been removed. And at a lab in Baltimore, researchers are working around the clock to recruit trial participants, prepare vaccine doses, and study results. 

Guest: Dr. Kirsten Lyke, lead investigator on COVID-19 vaccine trials at the University of Maryland’s Center for Vaccine Development and Global Health. 

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - Will Michael Flynn Get Away With It?

The criminal case against former Trump adviser Michael Flynn has been full of plot-twists. But the biggest about-face came last week, when the Department of Justice moved to drop the case entirely. Lawyers who had worked on the investigation registered their disgust by refusing to sign the motion. U.S. Attorney General William Barr says he hopes history will look kindly on his decision. Critics say the move undermines any future attempt to hold the Trump administration accountable.

Guest: Dahlia Lithwick, legal correspondent for Slate and host of the podcast Amicus

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - Italy Emerges From Lockdown. Slowly.

We spoke to Greta Privitera back in mid-March, a few weeks after she and her family isolated themselves at home in northern Italy. Now, with Italy taking baby steps toward normalcy, Greta says she’s enjoying her walks outside, she still worries about another surge in COVID-19 cases. And by the look of things, she's not alone.

Guest: Greta Privitera, a journalist living in Milan. Read her latest dispatch for Slate.  

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - The Shooting of Ahmaud Arbery

Ahmaud Arbery was shot dead on a Sunday afternoon in southern Georgia. He had been jogging a few miles from his home. The shooting happened on February 23. It took more than two months for officials to make any arrests. Why?

Guest: Christian Boone, public safety reporter for the AJC. 

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Amicus With Dahlia Lithwick | Law, justice, and the courts - Big Days for Justice


Dahlia Lithwick is joined by Susan Hennessey, national security analyst and executive editor of Lawfare to discuss the ramifications of the Justice Department’s decision to drop the case against Michael Flynn. Later in the show, Lithwick is joined by veteran Supreme Court watcher Linda Greenhouse to unpack the new format for Supreme Court arguments: a teleconference carried live on C-SPAN, with a close look at the birth control case you might have missed. 


In the Slate Plus segment, Mark Joseph Stern on how Flushgate could affect post-pandemic openness at the Supreme Court and which justice is crushing the conference calls. Sign up for Slate Plus now to listen and support our show.


Podcast production by Sara Burningham.


Learn more about your ad choices. Visit megaphone.fm/adchoices

What Next | Daily News and Analysis - TBD | Should You Get an Antibody Test?

Yesterday, New York City announced that it would provide 140,000 free antibody tests to residents who want to know if they have been exposed to the coronavirus. And New York isn’t alone: large-scale antibody testing is ramping up around the country.


But with faulty tests flooding the market and questions about whether a positive test really confers immunity are antibody tests really worth the bother?


Guests: Shannon Palus, staff writer for Slate, and Dr. Natalie E. Dean, assistant professor of biostatistics at the University of Florida.

Learn more about your ad choices. Visit megaphone.fm/adchoices